行情

SLP

SLP

Simulations Plus
NASDAQ

实时行情|Nasdaq Last Sale

34.83
+0.23
+0.66%
盘后: 34.83 0 0.00% 16:09 11/15 EST
开盘
34.60
昨收
34.60
最高
35.31
最低
34.52
成交量
8.69万
成交额
--
52周最高
41.95
52周最低
17.18
市值
6.13亿
市盈率(TTM)
79.81
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SLP 新闻

  • 收盘:美股再创新高 道指首次跨越28000点里程碑
  • 新浪美股.3小时前
  • 周五美油期货收高1.7% 布油上涨1.6%
  • 新浪美股.3小时前
  • 分析师:某位投资大佬可能正在“嗅探”Netflix
  • 新浪财经.3小时前
  • FAA局长:737 MAX机型获复飞批准"不受时间表指引"
  • 新浪美股.4小时前

更多

所属板块

先进医疗设备和技术
+2.55%
医疗设备和用品
+1.93%

热门股票

名称
价格
涨跌幅

SLP 简况

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
展开

Webull提供Simulations Plus, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。